tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 471 are a BUY (82.49%), 91 are a HOLD (15.94%), 9 are a SELL (1.58%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 44.51% that have a potential upside of 44.11% achieved within 235 days.
David Nierengarten’s has documented 1,183 price targets and ratings displayed on 83 stocks. The coverage is on Healthcare, Communication Services, Technology, Energy, Consumer Cyclical sectors.
Most recent stock forecast was given on TLX, Telix Pharmaceuticals at 22-Sep-2026.
Analyst best performing recommendations are on ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES).
The best stock recommendation documented was for ABVX (ABIVAX SA AMERICAN DEPOSITARY SHARES) at 6/2/2026. The price target of $90 was fulfilled within 1 day with a profit of $17.5 (24.14%) receiving and performance score of 241.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Jun-2026
$95
$44 (86.27%)
$95
Buy Since 03-Oct-2024
$81
$30 (58.82%)
$85
7 days ago
(23-Sep-2026)
3/5 (60%)
$30.23 (59.54%)
388
Buy Since 16-Feb-2024
$93
$42 (82.35%)
$95
4 months 26 days ago
(04-May-2026)
0/6 (0%)
$23.22 (33.28%)
Buy Since 13-Oct-2025
$63
$12 (23.53%)
$79
5 months 8 days ago
(22-Apr-2026)
2/6 (33.33%)
$9.45 (17.65%)
67
Buy Since 17-Mar-2026
$60
$9 (17.65%)
$90
5 months 9 days ago
(21-Apr-2026)
1/3 (33.33%)
$8.18 (15.79%)
6
Which stock is David Nierengarten most bullish on?
Which stock is David Nierengarten most reserved on?
What Year was the first public recommendation made by David Nierengarten?
